nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Rivastigmine—Alzheimer's disease	0.302	0.432	CbGbCtD
Tasosartan—CYP3A4—Donepezil—Alzheimer's disease	0.242	0.345	CbGbCtD
Tasosartan—CYP3A4—Galantamine—Alzheimer's disease	0.156	0.223	CbGbCtD
Tasosartan—Irbesartan—PTGS1—Alzheimer's disease	0.00229	0.287	CrCbGaD
Tasosartan—Candesartan—PTGS1—Alzheimer's disease	0.00229	0.287	CrCbGaD
Tasosartan—Losartan—ACE—Alzheimer's disease	0.00183	0.23	CrCbGaD
Tasosartan—Irbesartan—CYP2D6—Alzheimer's disease	0.00156	0.195	CrCbGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000772	0.00264	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000755	0.00258	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000745	0.00255	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—SST—Alzheimer's disease	0.000745	0.00255	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Alzheimer's disease	0.000731	0.0025	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—APP—Alzheimer's disease	0.000726	0.00248	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000721	0.00247	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000715	0.00245	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000712	0.00244	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000702	0.0024	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1B—Alzheimer's disease	0.000699	0.00239	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CASP3—Alzheimer's disease	0.000697	0.00238	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APH1A—Alzheimer's disease	0.000692	0.00237	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GAL—Alzheimer's disease	0.00069	0.00236	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000685	0.00234	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000674	0.00231	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LRP1—Alzheimer's disease	0.000658	0.00225	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000651	0.00223	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GFAP—Alzheimer's disease	0.000642	0.0022	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GAL—Alzheimer's disease	0.000642	0.0022	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000621	0.00213	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000605	0.00207	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.000597	0.00204	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000592	0.00202	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—Alzheimer's disease	0.000591	0.00202	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000591	0.00202	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—A2M—Alzheimer's disease	0.000566	0.00194	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000563	0.00193	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000558	0.00191	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000548	0.00188	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—Alzheimer's disease	0.000544	0.00186	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000543	0.00186	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—NPY—Alzheimer's disease	0.000542	0.00186	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—IAPP—Alzheimer's disease	0.000539	0.00184	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000535	0.00183	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000529	0.00181	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000529	0.00181	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CRH—Alzheimer's disease	0.000523	0.00179	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—F2—Alzheimer's disease	0.000519	0.00177	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000517	0.00177	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.000512	0.00175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PYY—Alzheimer's disease	0.000511	0.00175	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—Alzheimer's disease	0.000507	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000507	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NPY—Alzheimer's disease	0.000504	0.00173	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IAPP—Alzheimer's disease	0.000501	0.00172	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—NPS—Alzheimer's disease	0.000496	0.0017	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CRH—Alzheimer's disease	0.000487	0.00167	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR5—Alzheimer's disease	0.00048	0.00164	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—SST—Alzheimer's disease	0.000473	0.00162	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000472	0.00162	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.00047	0.00161	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00047	0.00161	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000467	0.0016	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000464	0.00159	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NPS—Alzheimer's disease	0.000461	0.00158	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—APP—Alzheimer's disease	0.000461	0.00158	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000459	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000457	0.00156	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000456	0.00156	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—F2—Alzheimer's disease	0.000454	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000452	0.00155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000443	0.00152	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SST—Alzheimer's disease	0.00044	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK2—Alzheimer's disease	0.00044	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GAB2—Alzheimer's disease	0.00044	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000438	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000436	0.00149	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000433	0.00148	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APP—Alzheimer's disease	0.000429	0.00147	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000427	0.00146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR6—Alzheimer's disease	0.000427	0.00146	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000423	0.00145	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.00042	0.00144	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000415	0.00142	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—F2—Alzheimer's disease	0.000412	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000405	0.00138	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.0004	0.00137	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000392	0.00134	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAL—Alzheimer's disease	0.00039	0.00133	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NGFR—Alzheimer's disease	0.000378	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CREB1—Alzheimer's disease	0.000375	0.00128	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000369	0.00126	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000367	0.00126	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000358	0.00122	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAL—Alzheimer's disease	0.000354	0.00121	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000351	0.0012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—S100B—Alzheimer's disease	0.000349	0.00119	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TTR—Alzheimer's disease	0.000345	0.00118	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000343	0.00118	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000339	0.00116	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF2—Alzheimer's disease	0.000332	0.00114	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1R—Alzheimer's disease	0.000321	0.0011	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LPL—Alzheimer's disease	0.000308	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000306	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000306	0.00105	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MEF2C—Alzheimer's disease	0.000305	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000305	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000305	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PYY—Alzheimer's disease	0.000302	0.00103	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCG—Alzheimer's disease	0.000299	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000298	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000296	0.00101	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NGF—Alzheimer's disease	0.000292	0.000998	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—Alzheimer's disease	0.000284	0.000971	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPS—Alzheimer's disease	0.00028	0.000959	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPY—Alzheimer's disease	0.000278	0.000952	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2A—Alzheimer's disease	0.000278	0.00095	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000277	0.000946	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CRH—Alzheimer's disease	0.000268	0.000919	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SST—Alzheimer's disease	0.000267	0.000915	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000267	0.000915	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDK5—Alzheimer's disease	0.000262	0.000896	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—F2—Alzheimer's disease	0.000262	0.000895	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—APP—Alzheimer's disease	0.000261	0.000892	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CALM1—Alzheimer's disease	0.000259	0.000886	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LEP—Alzheimer's disease	0.000258	0.000883	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—Alzheimer's disease	0.000258	0.000883	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CAV1—Alzheimer's disease	0.000256	0.000875	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPS—Alzheimer's disease	0.000255	0.000871	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000253	0.000867	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR6—Alzheimer's disease	0.000252	0.000862	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000251	0.000858	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ESR1—Alzheimer's disease	0.000246	0.000843	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000246	0.000841	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—F2—Alzheimer's disease	0.000243	0.000833	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SST—Alzheimer's disease	0.000243	0.000831	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000243	0.000831	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000238	0.000815	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—APP—Alzheimer's disease	0.000237	0.00081	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000233	0.000798	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000229	0.000783	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APH1A—Alzheimer's disease	0.000226	0.000772	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GSK3B—Alzheimer's disease	0.000223	0.000765	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000223	0.000764	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CREB1—Alzheimer's disease	0.000222	0.000759	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—INS—Alzheimer's disease	0.00022	0.000754	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NCSTN—Alzheimer's disease	0.00022	0.000752	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—Alzheimer's disease	0.000217	0.000742	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LRP1—Alzheimer's disease	0.000214	0.000733	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1—Alzheimer's disease	0.000213	0.00073	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAL—Alzheimer's disease	0.000209	0.000716	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GFAP—Alzheimer's disease	0.000209	0.000716	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—Alzheimer's disease	0.000193	0.000661	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.00019	0.00065	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000186	0.000638	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—A2M—Alzheimer's disease	0.000184	0.000631	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000184	0.000629	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000184	0.000628	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000182	0.000622	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000179	0.000611	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000172	0.00059	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000169	0.000577	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000166	0.000567	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000165	0.000565	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	0.000164	0.000562	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CASP3—Alzheimer's disease	0.000164	0.000562	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	0.000163	0.000559	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—Alzheimer's disease	0.000163	0.000558	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	0.000159	0.000543	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000156	0.000535	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000153	0.000524	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK8—Alzheimer's disease	0.000151	0.000516	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—Alzheimer's disease	0.00015	0.000515	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	0.00015	0.000514	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00015	0.000512	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000148	0.000506	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000147	0.000504	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000143	0.000491	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—Alzheimer's disease	0.000143	0.000491	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000143	0.000491	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000143	0.000489	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000142	0.000486	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APP—Alzheimer's disease	0.00014	0.000478	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—Alzheimer's disease	0.000139	0.000477	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	0.000134	0.000459	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000132	0.000451	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—Alzheimer's disease	0.000128	0.000437	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	0.000123	0.000421	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000122	0.000418	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	0.00012	0.000411	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	0.00012	0.000409	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	0.000114	0.000389	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	0.000108	0.00037	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	0.000108	0.000369	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—Alzheimer's disease	0.000105	0.00036	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	0.000105	0.000358	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	0.0001	0.000343	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	9.94e-05	0.00034	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	9.75e-05	0.000334	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—Alzheimer's disease	9.63e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	9.5e-05	0.000325	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	9.24e-05	0.000316	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA4—Alzheimer's disease	9.16e-05	0.000314	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	9.04e-05	0.000309	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—Alzheimer's disease	8.89e-05	0.000304	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	8.61e-05	0.000295	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	8.44e-05	0.000289	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	8.41e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	8.41e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	8.33e-05	0.000285	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	8.17e-05	0.000279	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	8.03e-05	0.000275	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2—Alzheimer's disease	7.93e-05	0.000271	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	7.79e-05	0.000267	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.76e-05	0.000266	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	7.47e-05	0.000256	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	7.28e-05	0.000249	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	7.22e-05	0.000247	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	7.19e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INS—Alzheimer's disease	7.18e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	7.07e-05	0.000242	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	6.95e-05	0.000238	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ND1—Alzheimer's disease	6.94e-05	0.000238	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	6.3e-05	0.000216	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.4e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	5.35e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	5.31e-05	0.000182	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	4.92e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	4.9e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	4.54e-05	0.000155	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.47e-05	0.000153	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.47e-05	0.000153	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.29e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	4.17e-05	0.000143	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.13e-05	0.000141	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.99e-05	0.000136	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.47e-05	0.000119	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.43e-05	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	3.43e-05	0.000117	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.25e-05	0.000111	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.25e-05	0.000111	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.19e-05	0.000109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	3.14e-05	0.000107	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.02e-05	0.000103	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	2.9e-05	9.91e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.85e-05	9.76e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.76e-05	9.46e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.38e-05	8.15e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.37e-05	8.12e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.17e-05	7.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.95e-05	6.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.82e-05	6.24e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.82e-05	6.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.8e-05	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.58e-05	5.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INS—Alzheimer's disease	1.55e-05	5.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.36e-05	4.66e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.25e-05	4.26e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.26e-06	2.14e-05	CbGpPWpGaD
